아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - omeprazolum inn - magasýruþolið hart hylki - 20 mg

아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - omeprazolum inn - magasýruþolið hart hylki - 10 mg

아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

franklin pharmaceuticals ltd. - gentamicinum súlfat - stungulyf, lausn - 100 mg/ml

유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - Ónæmisbælandi lyf - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

orion corporation - dexmedetomidine hydrochloride - meðvitandi sedation - psycholeptics - til róandi fullorðinsþjálfunaraðila sem krefjast róandi stigs ekki dýpra en vökva sem svar við munnlegri örvun (samsvarandi richmond agitation-sedation scale (rass) 0 til -3).

유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

tetris pharma b.v - glúkagon - sykursýki - brisi hormón, glycogenolytic hormón - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.

아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

haleon denmark aps - paracetamolum inn - mixtúra, dreifa - 24 mg/ml

아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - metronidazolum inn - krem - 10 mg/g

아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

evolan pharma ab - amorolfinum hýdróklóríð - lyfjalakk á neglur - 5 %

아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

evolan pharma ab - mometasonum fúróat - nefúði, dreifa - 50 míkróg/skammt